TY - JOUR
T1 - Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy
AU - Homkrailas, Piyavadee
AU - Ayoub, Walid S.
AU - Martin, Paul
AU - Bunnapradist, Suphamai
N1 - Funding Information:
Piyavadee Homkrailas and Walid S. Ayoub contributed equally to this work and are both co‐first authors. Piyavadee Homkrailas has no disclosures. Walid S. Ayoub has no disclosures pertinent to this submission. Paul Martin has no disclosures pertinent to this submission. Suphamai Bunnapradist has received support from FDA, NIDDK, NIAID, NIH, Astellas, Mallinckrodt, BMS, CareDx, Natera, Merck, Sanofi, Veloxis, Vitaeris, and OneLegacy Foundation.
Funding Information:
This work was supported in part by Health Resources and Services Administration contract HHSH250‐2019‐00001C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Funding Information:
This work was supported in part by Health Resources and Services Administration contract HHSH250-2019-00001C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022/2
Y1 - 2022/2
N2 - In 2017, United Network for Organ Sharing (UNOS) established the safety net policy with set criteria for offering kidney transplantation (KT) for patients who developed end-stage renal disease between 60 and 365 days after liver transplant (LT). We provide an update on the impact of the policy. We analyzed UNOS data of liver recipients transplanted between 1987 and 2020 who developed acute kidney injury requiring dialysis within 60 days before or after LT and subsequently listed for KT. We identified 407 patients who were listed for kidney after LT before policy and 248 patients after policy. Median waiting time to KT was shorter after policy (324 days vs. 2827 days). There was a higher proportion of candidates who were listed for subsequent KT within 1-year after policy (94.8% vs. 63.6%). KT rate was also higher after policy (87.7 vs. 30.7 per 100 patient-years at risk). Most importantly, we started to observe a net negative kidney utilization in end-stage liver disease setting (i.e., summation of simultaneous liver kidney and kidney after liver transplant in the first-year after LT has decreased from 1086 to 876 transplants in 2019). Such findings are consistent with a more efficient system and more appropriate allocation of organs.
AB - In 2017, United Network for Organ Sharing (UNOS) established the safety net policy with set criteria for offering kidney transplantation (KT) for patients who developed end-stage renal disease between 60 and 365 days after liver transplant (LT). We provide an update on the impact of the policy. We analyzed UNOS data of liver recipients transplanted between 1987 and 2020 who developed acute kidney injury requiring dialysis within 60 days before or after LT and subsequently listed for KT. We identified 407 patients who were listed for kidney after LT before policy and 248 patients after policy. Median waiting time to KT was shorter after policy (324 days vs. 2827 days). There was a higher proportion of candidates who were listed for subsequent KT within 1-year after policy (94.8% vs. 63.6%). KT rate was also higher after policy (87.7 vs. 30.7 per 100 patient-years at risk). Most importantly, we started to observe a net negative kidney utilization in end-stage liver disease setting (i.e., summation of simultaneous liver kidney and kidney after liver transplant in the first-year after LT has decreased from 1086 to 876 transplants in 2019). Such findings are consistent with a more efficient system and more appropriate allocation of organs.
UR - http://www.scopus.com/inward/record.url?scp=85118618973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118618973&partnerID=8YFLogxK
U2 - 10.1111/ctr.14522
DO - 10.1111/ctr.14522
M3 - Article
C2 - 34716954
AN - SCOPUS:85118618973
VL - 36
JO - Clinical Transplantation
JF - Clinical Transplantation
SN - 0902-0063
IS - 2
M1 - e14522
ER -